1 💰 商业科技 Ars Technica 2026-07-25 💬 RFK Jr.'s hand-picked committee approves manufacture of peptides he uses 揭露RFK Jr.亲信委员会无视安全数据，批准其自用肽类生产，监管标准遭质疑。 There's no human safety or efficacy data, but that no longer seems to matter. rfk jr. 肽类药物 审批争议 安全数据缺失 公共卫生政策